All Class III Devices & IVDs Subject to UDI Starting June 1, 2022
Source Node: 1121586
Time Stamp: Oct 5, 2021
Blogs – China Med Device
More Class II & III Medical Devices and IVDs Exempted from Clinical Trials
Source Node: 1121590
Time Stamp: Sep 24, 2021
Huge Changes Made on Hainan Policy: Faster Approval, Home Use Allowance and More
Source Node: 1087076
Time Stamp: Sep 17, 2021
Clinical Trial Data Submission Guideline: Requirements Clarified
Source Node: 1866736
Time Stamp: Sep 15, 2021
Six Guidelines Issued on Nanomaterials, Nomenclature and Orthopedics
Source Node: 1866526
Time Stamp: Sep 9, 2021
Five Hospitals Began Pioneering Device Urgent Use Policy in Greater Bay Area; Government Guidance Published
Source Node: 1866092
Time Stamp: Sep 5, 2021
Historical Changes on China Medical Device and IVD Registration Effective October 1, 2021
Source Node: 1866086
Time Stamp: Sep 5, 2021
Three Keys Documents Accelerate Device Importation for Greater Bay Area
Source Node: 1121592
Time Stamp: Aug 24, 2021
Second Draft for Self-Test: Self Report Applicable for Class II and III Devices Now
Source Node: 1019262
Time Stamp: Aug 12, 2021
Cosmetics Production and Operation Measures Effective Jan 1, 2022
Source Node: 1019265
Time Stamp: Aug 11, 2021
NMPA Combination Products: Latest Classification Results
Source Node: 1019269
Time Stamp: Jul 29, 2021
Drug Approval Certificate No Longer Needed for Combination Product Registration
Source Node: 1019272
Time Stamp: Jul 29, 2021
Eleven Evaluation Reports from NMPA Reviewers: Roche and Sequent Medical on The List
Source Node: 987137
Time Stamp: Jul 23, 2021
NMPA Standards Revisions Plan: Eleven Mandatory Standards to be Issued in 2021
Source Node: 987139
Time Stamp: Jul 23, 2021
Three Cardio Device Manufacturers Proceed to Innovation Pathway
Source Node: 1857934
Time Stamp: Jul 9, 2021
New Passive Implantable Shelf-life Guideline Pays More Attention on Batch-to-Batch Variability
Source Node: 1019277
Time Stamp: Jun 29, 2021